Intelligence Platform

Patents

Browse 69 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10588983

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Mar 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10328130

Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions

HALOZYME, INC. · Granted Tue Jun 25 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10286044

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265410

Adverse side-effects associated with administration of an anti-hyaluronan agent and method

HALOZYME, INC. · Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10137104

Combination therapy with an anti-hyaluronan agent and therapeutic agent

HALOZYME, INC. · Granted Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10016491

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993529

Stable formulations of a hyaluronan-degrading enzyme

HALOZYME, INC. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9969998

Compositions of adenosine deaminase-2 (ADA2), variants thereof and methods of using same

HALOZYME, INC. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9913822

Combination therapy with an anti-hyaluronan agent and therapeutic agent

HALOZYME, INC. · Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9878046

Adverse side-effects associated with administration of an anti-hyaluronan agent and method

HALOZYME, INC. · Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9833498

Methods of treatment of collagen-mediated diseases and conditions

HALOZYME, INC. · Granted Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9775889

Methods of treatment of cellulite

HALOZYME, INC. · Granted Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9683985

Methods for assessing and identifying or evolving conditionally active therapeutic protein

HALOZYME, INC. · Granted Tue Jun 20 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677062

Hyaluronidase and factor VIII compositions

HALOZYME, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9677061

Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pha

HALOZYME, INC. · Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9562223

Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycopr

HALOZYME, INC. · Granted Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9458442

Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof

HALOZYME, INC. · Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9447401

PH20 polypeptide variants, formulations and uses thereof

HALOZYME, INC. · Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9333244

Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for

HALOZYME, INC. · Granted Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 05 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9284543

Neutral active soluble truncated PH20 polypeptides and uses thereof

HALOZYME, INC. · Granted Tue Mar 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9278124

Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and co

HALOZYME, INC. · Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9211315

Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycan

HALOZYME, INC. · Granted Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034323

Method for control of post-prandial glucose

HALOZYME, INC. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8927249

Extended soluble PH20 polypeptides and uses thereof

HALOZYME, INC. · Granted Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted